DIGTF yields 18181.82% · JNJ yields 2.14%● Live data
📍 DIGTF pulled ahead of the other in Year 1
Combined, DIGTF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DIGTF + JNJ for your $10,000?
Thruvision Group plc engages in development, manufacture, and sale of passive people-screening technology in the United Kingdom, rest of Europe, the Americas, the Asia-Pacific, the Middle East, and Africa. The company provides surface transportation security cameras for protecting the traveling public from terrorist attack; customs and border security cameras to check travelers for concealed contraband; entrance and public venue security cameras for screening visitors to detect weapons and explosives; loss prevention security cameras to detect and deter theft; and deployment accessories to provide operational flexibility. Its products are used in aviation security, retail supply chain loss prevention, customs and border control, and public area security. The company was formerly known as Digital Barriers plc and changed its name to Thruvision Group plc in November 2017. Thruvision Group plc was incorporated in 2010 and is headquartered in Abingdon, the United Kingdom.
Full DIGTF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.